The observed reduction in HR activity coupled with increased sensitivity to PARP inhibition in BCL-3 depleted cells, both in human CRC cells and in mice, suggests that loss of repair activity is at least in part responsible for greater DSB number. This evidence concerns the gene BCL3 and colorectal carcinoma.